Back

Colchicine serum levels in patients with chronic coronary syndrome

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Jalina Jannink

University Medical Center Utrecht, Utrecht (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Assessment of long-term safety of pro-angiogenic growth approaches in cardiovascular disease: A systematic review
Professor D. Bates (Nottingham, GB)
Abstract Slides
Presentation thumbnail
Leukotriene receptor antagonists and lower risk of major adverse cardiovascular events in patients with asthma
Assistant Professor J. Le Van (Montreal, CA)
Abstract Slides
Presentation thumbnail
A pharmacodynamic analysis of genotype-guided P2Y12-inhibitor monotherapy or dual antiplatelet therapy after PCI in patients with chronic coronary syndrome – the POPular STRATEGY study
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Anti-inflammatory effects of atorvastatin and colchicine combination in patients with acute or chronic coronary syndrome undergoing coronary angiography and/or PCI
Mr T. Trijitwatthanakoon (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Empagliflozin attenuates coronary atherosclerosis by promoting the differentiation of pericoronary adipose-derived stem cells
Mr S. Shi (Nanjing, CN)
Abstract Slides

Access the full session

Session thumbnail
Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Low-dose colchicine in patients treated with percutaneous coronary interventions for myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
29 August 2020
thumbnail
Congress Presentation
Association between lipoprotein (a) level and chronic cardio-renal syndrome in patients with coronary artery disease
29 June 2021
thumbnail
Congress Presentation
Plasma trough concentrations of antihypertensive drugs for the assessment of treatment adherence: a meta-analysis
28 August 2020
thumbnail
Congress Presentation
Increase in serum TTR levels observed with acoramidis treatment in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): insights from ATTRibute-CM and its open-label extension
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources